New clue in endometriosis: could a protein in blood and fluid help diagnose the disease?

NCT ID NCT07164196

Completed Knowledge-focused Sponsor: Ankara City Hospital Bilkent Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study measured levels of a protein called ANGPTL4 in the blood and pelvic fluid of 80 women—some with endometriosis and some healthy. The goal was to see if this protein could be a better marker for the disease than the current CA-125 test. Researchers hope it might lead to a more accurate way to diagnose endometriosis without surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If ANGPTL4 proves to be a reliable marker, it could lead to a new blood test to help diagnose endometriosis more accurately.
What could go wrong: This is a small, completed observational study, not a treatment trial. The findings may not be strong enough to change current diagnostic practices.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANGIOPOIETIN-LIKE PROTEIN-4 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

endometriosis Inflammation Pelvic Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANGIOPOIETIN-LIKE PROTEIN-4 ENDOMETRIOSIS PELVIC PAIN

Contacts and locations

Locations

Ankara Bilkent City Hospital

Ankara, Not Valid, 06100, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.